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The proverb ‘‘Words are like cherries’’, meaning that when you start talking subjects pop up and you end up
with long conversations, just like cherries coming out of the plate in chains when you pick one, may also be
applied to epidemiological research. A sequence of epidemiological studies, each being drawn from the
previous, is presented as an example of how each investigation may raise new questions to be addressed in
following studies.
This description stresses the need for appropriate planning and the usefulness of pilot testing to depict
inadequacies that can hardly be anticipated without ﬁeld work. I intend to illustrate how epidemiological
research can provide a deep approach to research questions, as long as ﬁndings are properly interpreted
and suboptimal methodological options are taken into account in future investigations.
& 2008 SESPAS. Published by Elsevier Espan˜a, S.L. All rights reserved.Los estudios epidemiolo´gicos son como las cerezas, van una detra´s de la otraPalabras clave:
Me´todos
Cuestionarios
Estudios de utilizacio´n de medicamentos
MozambiqueR E S U M E N
El proverbio ‘‘Las palabras son como las cerezas’’ que expresa co´mo cuando empezamos a hablar los
asuntos van surgiendo de manera encadenada y terminamos con largas conversaciones, del mismo modo
en que las cerezas que salen del plato encadenadas cuando cogemos una, puede tambie´n puede ser
aplicado a la investigacio´n epidemiolo´gica. Una secuencia de estudios epidemiolo´gicos, cada uno derivado
del anterior, se presenta como un ejemplo de co´mo cada investigacio´n puede derivar en nuevas cuestiones
en los estudios siguientes.
Esta descripcio´n subraya la necesidad de una planiﬁcacio´n adecuada ası´ como la utilidad de los estudios
piloto para describir las deﬁciencias que difı´cilmente podrı´an haber sido anticipadas sin trabajo de campo.
Se pretende ilustrar como la investigacio´n epidemiolo´gica puede proporcionar un enfoque profundo a
cuestiones de investigacio´n, siempre y cuando los resultados sean interpretados correctamente y las
opciones metodolo´gicas subo´ptimas sean tenidas en cuenta en futuras investigaciones.
& 2008 SESPAS. Publicado por Elsevier Espan˜a, S.L. Todos los derechos reservados.In this ﬁeld note I present a set of original results, preceded by
the chain of reasoning that brought us to them, and followed by
the research that was subsequently generated.
The seed for the described investigations was a survey
conducted in Portugal, aiming to quantify the prevalence of drug
allergy in University students, which allowed us to ﬁll a gap in the
knowledge of the descriptive epidemiology of drug allergy in our
population.1 We had the opportunity to replicate this study in
Mozambique, motivated by the novelty of such data in the African
setting.2 The questionnaire was carefully adapted to the local
speciﬁcities, but we were surprised by an 18% prevalence of self-
reported chloroquine allergy in the black population. (Table 1).
No similar studies frommalaria endemic or epidemic countries
had been published before, but in the large number of citizens
from developed countries exposed to chloroquine for malaria
chemoprophylaxis, chloroquine has never been described as
having a strong allergenic potential. On the other hand, chlor-
oquine-induced pruritus, apparently a non IgE-mediated condi-
tion, has been described as frequent in black subjects,
compromising treatment adherence.3,4 Evidence of the resurgence
of chloroquine-susceptible falciparum malaria about a decade
after its withdrawal5 resulted in boosted relevance for issues
related to the appropriateness of chloroquine use.ado por Elsevier Espan˜a, S.L. TodoTaking advantage of the ethnic diversity of the Mozambican
population, we conducted a new cross sectional study, in 2004,
ultimately aiming to understand the dose-response relation
between chloroquine use and pruritus and the effect of this
common side effect on future treatment options.6 Also, local
pharmacists had the perception that antihistaminic drugs or
prednisolone were frequently used in association with
chloroquine, in an attempt to minimize its associated pruritus,
despite the lack of evidence for the beneﬁt of such procedure.
Therefore, we quantiﬁed the use of the different antimalarial
drugs, antihistaminic drugs and prednisolone, as described
below.
A self-administered questionnaire (Appendix 1) was used to
collect information on the treatment of the latest malaria episode,
when applicable. The pharmacological treatment was assessed by
asking speciﬁcally for each of the antimalarial drugs available in
Mozambique at that time, and the list of drugs also included
the items ‘‘antihistaminic drugs (e.g. chlorpheniramine,
loratadine, etc.)’’ and ‘‘prednisolone’’ (most drugs are well known
by their generic name in this setting). Four hundred and
eighty eight subjects were evaluated, representing approximately
50% of the total number of students in diurnal classes. Eighteen
students (3.6%) refused to participate. Respondents’ median
age was 21 years (range: 18 to 51 years), 65.0% were females,
29.9% attended health related courses, 73.5% had had malaria
at least once.s los derechos reservados.
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Table 1
Main characteristics and results of the studies presented in this report
Authors, yearref Objective City, country
year
Participants Main results Questions raised/
comments
Falca˜o et al, 20031 To quantify the
prevalence of self-
reported drug allergy.
Porto, Portugal
2001
University students from
public and private schools,
including health and non-
health related courses
(n ¼ 2150, 67.6% females).
Life prevalence of drug allergy (X1
episodes): 7.7%. b-lactams (3.1%)
and NSAIDs (2.1%) were the most
frequently involved drugs.
Lunet et al, 20052 To quantify the
prevalence of self-
reported drug allergy.
Maputo,
Mozambique
2003
University students from a
private school, including
health and non-health
related courses (n ¼ 447,
55.3% women), and non-
teaching staff (n ¼ 62,
56.5% females).
Life prevalence of drug allergy (X1
episodes): 25.0%. Chloroquine
(11.8%), b-lactams (3.9%), aspirin
(2.8%), and co-trimoxazol (2.2%)
were the most frequently involved
drugs.
The prevalence of self-
reported allergy to
chloroquine was higher
than expected.
Chloroquine allergy was more
frequent in Blacks (18.0% vs. 3.2%),
in the staff (24.2% vs. 11.0%), and
increased with age. No such
pattern was observed for allergy to
drugs other than chloroquine.
Different pattern of
association with socio-
demographic factors were
observed for self-reported
allergy to chloroquine and
to other drugs.
Gama et al, 20086 To quantify the
prevalence of
chloroquine-induced
pruritus and its
associated factors.
Maputo,
Mozambique
2004
University students from a
private school, including
health and non-health
related courses (n ¼ 488,
65.0% females).
The prevalence of chloroquine use
was 67.3%, and chloroquine-
induced was reported by 25.9%of
the subjects, more often by Blacks
(35.6% vs. 13.4%) and older
subjects.
The frequency of
chloroquine-induced
pruritus was similar to the
prevalence of self-reported
allergy to chloroquine.
The recall of pruritus associated
with the use of chloroquine
increased with the number of
malaria episodes during life (1 vs.
X5 episodes: 9.0% vs. 42.9%).
To describe the use of
antimalarial drugs,
antihistaminic drugs
and prednisolone in
malaria episodes (see
Appendix 1). *
The use of antihistaminic drugs
and prednisolone in the latest
malaria episode was reported by
1.3% and 1.9% of the subjects,
respectively.
The use of antihistaminic
drugs and prednisolone
during malaria episodes
was less frequent than
expected.
Lunet et al, 20088 To compare the recall
of antimalarial
treatments using two
versions of a
questionnaire in which
the answering options
are presented in a
different order.
Maputo,
Mozambique
2006
University students from a
private school, including
health and non-health
related courses (n ¼ 504,
60.8% females).
The recall of quinine utilization
was higher with the questionnaire
version displaying quinine at the
top of the list of options (19.5% vs.
11.6%), and similar results were
observed for artemisinine/
artesunate (16.5% vs. 7.3%).
The ﬁrst antimalarial
drugs being presented as
answering options were
more likely to be selected.
To describe the use of
antimalarial drugs,
antihistaminic drugs
and prednisolone in
malaria episodes (see
Appendix 2). *
The use of antihistaminic drugs
and prednisolone in the latest
malaria episode was reported by
17.7% and 1.5% of the subjects,
respectively.
The recall of
antihistaminic drugs use
in a malaria episode was
higher in the 2006 than in
the 2004 survey (which
differed in the
questionnaire format, see
appendixes 1 and 2).
The objectives signed with * are addressed in this report, but were not explored in the previously published articles.
NSAIDs-non-steroidal anti-inﬂammatory drugs.
N. Lunet / Gac Sanit. 2009;23(5):479–482480The proportion of subjects reporting to have used chloroquine
before was 67.3%, from which 25.9% reported episodes of intense
pruritus associated with chloroquine, supporting the hypothesis
that the terms ‘‘allergy’’ and ‘‘pruritus’’ may have been interpreted
as interchangeable by the participants, which could explain the
unexpectedly high prevalence of self-reported chloroquine allergy
observed in the ﬁrst survey. Further research, namely qualitative,
could contribute to further understand this phenomenon.
Surprisingly, the use of antihistaminics and prednisolone in the
latest malaria episode was reported by only 1.3% and 1.9%,
respectively.
The more plausible explanation for these low prevalence
estimates is the fact that the questionnaire referred to drugs usedin the latest treatment for malaria, not distinguishing between
antimalarial treatments and other drugs that could be used during
a malaria episode, as it is know that more speciﬁc questions
contribute to a better recall.7 This hypothesis was tested when the
survey was repeated,8 two years later, using a questionnaire with
separate headings for the antimalarial and for the drugs that could
be used to relief pruritus (Appendix 2). The methods used and the
population evaluated in the 2006 survey were similar to those in
2004. We evaluated 504 subjects, approximately 50% of the total
number of students in the institution in diurnal classes. Fourteen
students (2.7%) refused to participate. Respondents’ median age
was 20 years (range: 18 to 57 years), 60.8% were females, 33.8%
attended health related courses, and 72.6% had had malaria at
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N. Lunet / Gac Sanit. 2009;23(5):479–482 481least once. The proportion of drug use in 2004 and 2006 was
compared with the w2 test, or the Fisher exact test when
appropriate.
The reported frequency of antihistaminic use during the latest
malaria episode was substantially higher in the 2006 survey
(17.7% vs. 1.3%, po0.001), but no statistically signiﬁcant differ-
ences were observed for prednisolone (1.5% vs. 1.9%, p ¼ 0.70). In
the survey performed in 2006, the proportion of subjects using
chloroquine in the treatment of malaria was 57% when the latest
episode took place before 2004, and 42%, 18% and 12% in the
episodes occurring in 2004, 2005 and 2006, respectively, reﬂect-
ing the replacement of chloroquine by artemisin-based combina-
tion treatments as ﬁrst-line therapy for falciparum malaria in all
endemic areas in Africa. Among the subjects who had their latest
malaria episode before 2004, the prevalence of antihistaminic
drug use was 17.7%, and 2.3% of the participants used predniso-
lone in association with the antimalarial drugs.
The differences observed in responses to these two question-
naires of different structure are much larger than could be
expected given the results from previous studies showing the
variation in the completeness of ascertainment of drug exposure
according to how the participants are questioned.7 We hypothe-
sized that the underreporting could have been further increased
by the fact that respondents tend to choose the ﬁrst response
options when questions are presented visually (as in self-
administered questionnaires),9 since the drugs with no antima-
larial effect were placed at the end of the list. We could expect
that after selecting an antimalarial drug most subjects did not
read the rest of the options. This hypothesis was also tested in the
2006 survey, using an experimental design8 to compare two
alternative versions of the questionnaire, differing only in the
order in which each proposed drug was presented in the responseoptions (quinine and most frequently used drugs presented ﬁrst
vs. less frequently used drugs ﬁrst and quinine at the end). This
analysis showed that the ﬁrst antimalarial drugs being presented
as answering options were more likely to be selected.
Taken together, these results show that symptomatic treat-
ment of itching is more likely to be recalled when a speciﬁc
question is placed for antihistaminic drugs and most of the times
ignored when the answering option for antihistaminic drugs is
presented together with antimalarial drugs.
The proverb ‘‘Words are like cherries’’, meaning that when you
start talking subjects pop up and you end up with long
conversations, just like cherries coming out of the plate in chains
when you pick one, may also be applied to epidemiological
research. Here I presented a sequence of epidemiological studies,
each being drawn from the previous, as an example of how each
investigation may raise new questions to be addressed in
following studies.
To some extent, this example may be seen as an exercise of
trial and error, which rarely can be conducted by a single
researcher or research group due to the lengthy and complex
nature of epidemiological research in general, stressing the need
for in depth knowledge of the study subject, appropriate planning
and pilot testing. The conduction of small-scale tests of the
methods and procedures to be used on a larger scale epidemio-
logical research10 is an important component of the research
protocol, useful to depict inadequacies that can hardly be
anticipated without ﬁeld work.
This ‘‘chain’’ of studies, however, may also be described as an
example of how epidemiological research can be conducted with
reasonable depth, capitalizing a proper interpretation of the
ﬁndings and the need to take consequences of suboptimal
methodological options into account on new investigations.Appendix 1
Structure of the questionnaire used in the 2004 survey to evaluate malaria treatment (including antimalarial drugs, antihistaminic
drugs, and prednisolone).1. Did you ever have malaria?
0 & no1 & yes
If you answered no, please go to question 2
If you answered yes, please answer the following questions
1.1. How many times did you have malaria in you life?
j__j__j
1.2. The latest time you had malaria, which drugs did you take for treatment?
Quinine ———————————————————————————————————————————————————————————————————————————————— 0& no 1& yes
Chloroquine ——————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Artemisinine/artesunate ————————————————————————————————————————————————————————————— 0 & no 1 & yes
Halofantrine (Halfans) —————————————————————————————————————————————————————————————— 0 & no 1 & yes
Meﬂoquine ———————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Sulfadoxine-pyrimethamine (Fansidars) —————————————————————————————————————————— 0 & no 1 & yes
Tetracyclines —————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Clindamycin ——————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Antihistaminic drugs (e.g. clorfeniramine, loratidine, etc.) ————————————————————— 0 & no 1 & yes
Prednisolone ——————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Other ———————————————————————————————————————————————————————————————————————————————— 0 & no 1 & yes
Please specify which other drug(s)?__________________________________________
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Structure of the questionnaire used in the 2006 survey to evaluate malaria treatment (including antimalarial drugs and antipruritic
drugs separately).1. Did you ever have malaria?
0 & no 1 & yes
If you answered no, please go to question 2
If you answered yes, please answer the following questions
1.1. How many times did you have malaria in you life?
j__j__j
1.2. In which year did you have malaria for the latest time?
j__j__j__j__j
1.3. In the latest time you had malaria, which drugs did you take for treatment?
Please read all the drugs in the list and select those that you took in the latest time you had malaria
You may select more than one option
Quinine ——————————————————————————————————————————————————————————————————————————————————————— &
Chloroquine (Resochinas) ————————————————————————————————————————————————————————————————————————————— &
Sulfadoxine-pyrimethamine (Fansidars) ————————————————————————————————————————————————————————————————————— &
Amodiaquine ———————————————————————————————————————————————————————————————————————————————————— &
Halofantrin (Halfans) ——————————————————————————————————————————————————————————————————————————————— &
Artemisinine/artesunate (Arinates) ——————————————————————————————————————————————————————————————————————— &
Meﬂoquine ————————————————————————————————————————————————————————————————————————————————————— &
Lumefantrin+Artemeter (Coartems) ——————————————————————————————————————————————————————————————————————— &
Tetracyclines/doxicycline ————————————————————————————————————————————————————————————————————————————— &
Clindamycin ———————————————————————————————————————————————————————————————————————————————————— &
Other ———————————————————————————————————————————————————————————————————————————————————————— &
Please specify which other drug(s)?______________________________
1.4. In the latest time you had malaria, did you take any of these drugs?
Please select those that you took in the last time you had malaria
You may select more than one option
Antihistaminic/antiallergic drugs (e.g. chlorpheniramine, loratadine, Claritines, etc.) &
Prednisolone ———————————————————————————————————————————————————————————————————————————————————— &
Other ——————————————————————————————————————————————————————————————————————————————————————————
Please specify which other drug(s)?_____________________________________References
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